Cargando…

General intelligence in adult patients with early- and adult-onset schizophrenia

INTRODUCTION: Early-onset schizophrenia (EOS) is a relatively uncommon disorder with psychotic symptoms emerging before 18 years of age. Although still under debate, EOS may be a more severe disorder relative to adult-onset schizophrenia (AOS), with worse prognosis. Cognitive deficits are a core fea...

Descripción completa

Detalles Bibliográficos
Autores principales: Calkova, T., Mørch-Johnsen, L., Elle Smelror, R., Nordbø Jørgensen, K., Cervenka, S., Collste, K., Vaskinn, A., Margrethe Myhre, A., Andreassen, O. A., Ueland, T., Agartz, I., Andreou, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434486/
http://dx.doi.org/10.1192/j.eurpsy.2023.1048
_version_ 1785091901881319424
author Calkova, T.
Mørch-Johnsen, L.
Elle Smelror, R.
Nordbø Jørgensen, K.
Cervenka, S.
Collste, K.
Vaskinn, A.
Margrethe Myhre, A.
Andreassen, O. A.
Ueland, T.
Agartz, I.
Andreou, D.
author_facet Calkova, T.
Mørch-Johnsen, L.
Elle Smelror, R.
Nordbø Jørgensen, K.
Cervenka, S.
Collste, K.
Vaskinn, A.
Margrethe Myhre, A.
Andreassen, O. A.
Ueland, T.
Agartz, I.
Andreou, D.
author_sort Calkova, T.
collection PubMed
description INTRODUCTION: Early-onset schizophrenia (EOS) is a relatively uncommon disorder with psychotic symptoms emerging before 18 years of age. Although still under debate, EOS may be a more severe disorder relative to adult-onset schizophrenia (AOS), with worse prognosis. Cognitive deficits are a core feature of schizophrenia, accounting for a large part of the detrimental effect of the disorder and may reflect underlying neurodevelopmental disturbances. Some but not all previous studies show that the magnitude of cognitive deficits, including intelligence quotient (IQ), in patients with schizophrenia is dependent on the age of onset. OBJECTIVES: We aimed to assess IQ in adult patients with EOS and AOS, and healthy controls. We hypothesized that patients with EOS would show lower IQ than those with AOS, and both patient groups lower IQ than HC. METHODS: We included 136 adult patients with EOS (mean age: 24.7 (7.7) years, mean duration of illness: 9.3 (8.5) years, 50% women), 382 patients with AOS (mean age: 32.4 (9.5) years, mean duration of illness: 5.7 (6.6) years, 40.1% women) and 896 adult healthy controls (mean age: 33.2 (9.2) years, 47.1% women). We assessed current IQ with the Wechsler Abbreviated Scale of Intelligence (WASI) which yielded verbal (VIQ), performance (PIQ) and full-scale IQ (FIQ) scores. In a post-hoc analysis, we estimated premorbid IQ using the National Adult Reading Test (NART). We applied analyses of covariance (ANCOVAs) to investigate the putative differences in IQ scores and IQ change between patients with EOS, patients with AOS and healthy controls. RESULTS: In sex-, and age-adjusted models, FIQ and PIQ, but not VIQ, were significantly lower in EOS than in AOS (p=0.03, p<0.001 and p=0.428, respectively) (Image). Patients with EOS had fewer years of education than patients with AOS (p<0.001); the PIQ but not the FIQ difference between EOS and AOS remained significant after adjustment for education years (p=0.016 and p=0.333, respectively). Both patient groups had significantly lower IQ scores than healthy controls (Image). Further, patients with EOS and patients with AOS did not significantly differ in estimated premorbid IQ (109 and 110 units, respectively, p=0.092), whereas patients with EOS had a significantly larger estimated IQ decline after the disease onset compared to patients with AOS (12 and 9 units decline, respectively, p=0.015). Image: CONCLUSIONS: Our findings show that adult patients with EOS have significantly lower PIQ and FIQ scores, and significantly larger IQ decline after the disease onset, but not lower premorbid IQ, compared to patients with AOS. The adolescent onset of psychotic symptoms is linked, as expected, to fewer total years of education, which appears to explain the lower FIQ but only partially the lower PIQ in EOS, which may thereby be linked to the disorder per se. DISCLOSURE OF INTEREST: T. Calkova: None Declared, L. Mørch-Johnsen: None Declared, R. Elle Smelror: None Declared, K. Nordbø Jørgensen: None Declared, S. Cervenka: None Declared, K. Collste: None Declared, A. Vaskinn: None Declared, A. Margrethe Myhre: None Declared, O. A. Andreassen Consultant of: HealthLytix, Speakers bureau of: Lundbeck and Sunovion, T. Ueland: None Declared, I. Agartz: None Declared, D. Andreou: None Declared
format Online
Article
Text
id pubmed-10434486
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104344862023-08-18 General intelligence in adult patients with early- and adult-onset schizophrenia Calkova, T. Mørch-Johnsen, L. Elle Smelror, R. Nordbø Jørgensen, K. Cervenka, S. Collste, K. Vaskinn, A. Margrethe Myhre, A. Andreassen, O. A. Ueland, T. Agartz, I. Andreou, D. Eur Psychiatry Abstract INTRODUCTION: Early-onset schizophrenia (EOS) is a relatively uncommon disorder with psychotic symptoms emerging before 18 years of age. Although still under debate, EOS may be a more severe disorder relative to adult-onset schizophrenia (AOS), with worse prognosis. Cognitive deficits are a core feature of schizophrenia, accounting for a large part of the detrimental effect of the disorder and may reflect underlying neurodevelopmental disturbances. Some but not all previous studies show that the magnitude of cognitive deficits, including intelligence quotient (IQ), in patients with schizophrenia is dependent on the age of onset. OBJECTIVES: We aimed to assess IQ in adult patients with EOS and AOS, and healthy controls. We hypothesized that patients with EOS would show lower IQ than those with AOS, and both patient groups lower IQ than HC. METHODS: We included 136 adult patients with EOS (mean age: 24.7 (7.7) years, mean duration of illness: 9.3 (8.5) years, 50% women), 382 patients with AOS (mean age: 32.4 (9.5) years, mean duration of illness: 5.7 (6.6) years, 40.1% women) and 896 adult healthy controls (mean age: 33.2 (9.2) years, 47.1% women). We assessed current IQ with the Wechsler Abbreviated Scale of Intelligence (WASI) which yielded verbal (VIQ), performance (PIQ) and full-scale IQ (FIQ) scores. In a post-hoc analysis, we estimated premorbid IQ using the National Adult Reading Test (NART). We applied analyses of covariance (ANCOVAs) to investigate the putative differences in IQ scores and IQ change between patients with EOS, patients with AOS and healthy controls. RESULTS: In sex-, and age-adjusted models, FIQ and PIQ, but not VIQ, were significantly lower in EOS than in AOS (p=0.03, p<0.001 and p=0.428, respectively) (Image). Patients with EOS had fewer years of education than patients with AOS (p<0.001); the PIQ but not the FIQ difference between EOS and AOS remained significant after adjustment for education years (p=0.016 and p=0.333, respectively). Both patient groups had significantly lower IQ scores than healthy controls (Image). Further, patients with EOS and patients with AOS did not significantly differ in estimated premorbid IQ (109 and 110 units, respectively, p=0.092), whereas patients with EOS had a significantly larger estimated IQ decline after the disease onset compared to patients with AOS (12 and 9 units decline, respectively, p=0.015). Image: CONCLUSIONS: Our findings show that adult patients with EOS have significantly lower PIQ and FIQ scores, and significantly larger IQ decline after the disease onset, but not lower premorbid IQ, compared to patients with AOS. The adolescent onset of psychotic symptoms is linked, as expected, to fewer total years of education, which appears to explain the lower FIQ but only partially the lower PIQ in EOS, which may thereby be linked to the disorder per se. DISCLOSURE OF INTEREST: T. Calkova: None Declared, L. Mørch-Johnsen: None Declared, R. Elle Smelror: None Declared, K. Nordbø Jørgensen: None Declared, S. Cervenka: None Declared, K. Collste: None Declared, A. Vaskinn: None Declared, A. Margrethe Myhre: None Declared, O. A. Andreassen Consultant of: HealthLytix, Speakers bureau of: Lundbeck and Sunovion, T. Ueland: None Declared, I. Agartz: None Declared, D. Andreou: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10434486/ http://dx.doi.org/10.1192/j.eurpsy.2023.1048 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Calkova, T.
Mørch-Johnsen, L.
Elle Smelror, R.
Nordbø Jørgensen, K.
Cervenka, S.
Collste, K.
Vaskinn, A.
Margrethe Myhre, A.
Andreassen, O. A.
Ueland, T.
Agartz, I.
Andreou, D.
General intelligence in adult patients with early- and adult-onset schizophrenia
title General intelligence in adult patients with early- and adult-onset schizophrenia
title_full General intelligence in adult patients with early- and adult-onset schizophrenia
title_fullStr General intelligence in adult patients with early- and adult-onset schizophrenia
title_full_unstemmed General intelligence in adult patients with early- and adult-onset schizophrenia
title_short General intelligence in adult patients with early- and adult-onset schizophrenia
title_sort general intelligence in adult patients with early- and adult-onset schizophrenia
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434486/
http://dx.doi.org/10.1192/j.eurpsy.2023.1048
work_keys_str_mv AT calkovat generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT mørchjohnsenl generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT ellesmelrorr generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT nordbøjørgensenk generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT cervenkas generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT collstek generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT vaskinna generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT margrethemyhrea generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT andreassenoa generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT uelandt generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT agartzi generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia
AT andreoud generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia